Streetbeat News

Products Services

SNE

Sony has sold more than 40 million PlayStation 5 units since its launch in November 2020, according to Reuters.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 2:22 pm

AMZN

Amazon Technologies has filed a U.S. patent application #20230237980 for a hands-on artificial intelligence education service. This move could potentially expand Amazon's offerings in the education sector.

Portfolio Pulse from Charles Gross

July 27, 2023 | 1:56 pm

URGN

UroGen Pharma announced positive topline data from Phase 3 trials ATLAS and ENVISION studying UGN-102 for intravesical solution in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer. Both trials met primary endpoints, with ATLAS showing a 55% reduction of risk for recurrence, progression or death in patients who received UGN-102, and ENVISION showing a complete response rate of 79.2% at 3 months.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:54 pm

TSLA

Tesla has filed a U.S. patent application #20230237331 for neural networks for embedded devices. This indicates the company's ongoing efforts to improve its technology and maintain its competitive edge in the electric vehicle market.

Portfolio Pulse from Charles Gross

July 27, 2023 | 1:46 pm

AMZN

EIDO

FXI

GOOG

GOOGL

META

SNAP

TikTok has decided not to launch cross-border e-commerce services in Indonesia due to regulatory concerns. This decision may affect the competitive landscape of e-commerce in the region.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:27 pm

TLRY

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) and Great North Distributors, Inc. have renewed their national brokerage agreement. Under the agreement, Great North will continue to be the exclusive representative for Tilray’s full portfolio of recreational cannabis products across the Canadian marketplace, excluding Quebec. The renewed 4-year agreement will see Great North invest in incremental headcount, key account resources, brand education, and enhanced data capabilities to maximize sales revenue.

Portfolio Pulse from Vuk Zdinjak

July 27, 2023 | 1:27 pm

MSFT

SONY

Microsoft Corporation's next Xbox Update Preview Alpha will bring accessibility improvements for physically disabled players, allowing them to map keyboard keys to the Xbox Elite Wireless Controller Series 2 or the Xbox Adaptive Controller. However, there are some limitations as only single keys or functions can be mapped to controller buttons. Sony Interactive Entertainment, a division of Sony Group Corp., recently began accepting pre-orders for its PlayStation Access Controller, a customizable PS5 controller aimed at enhancing the gaming experience for players with disabilities.

Portfolio Pulse from Franca Quarneti

July 27, 2023 | 1:17 pm

SEMR

Semrush Holdings, Inc. (NYSE:SEMR) has announced two new AI-powered features for its Listing Management Tool. The features aim to help users respond to online reviews faster and find higher-quality keywords for their local business listings. The company has also advanced and expanded a number of its other tools using generative AI in 2023, including ContentShake, Kompyte GPT, and Purchase Conversion. Semrush has also enhanced its App Center offerings with new AI-backed apps.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 1:17 pm

AFRM

Affirm (NASDAQ:AFRM), a payment network, has announced a partnership with Cathay Pacific, a global airline based in Hong Kong, to become its exclusive U.S. pay-over-time partner. Approved Cathay Pacific customers can split the total cost of any flight into bi-weekly or monthly payments, for as low as 0% APR. Cathay Pacific joins over 245,000 Affirm merchants, including Adidas, American Airlines, Gucci, SeatGeek, Walmart, and more.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 1:16 pm

CELU

Celularity Inc. (NASDAQ:CELU) and Verséa Ophthalmics have announced an exclusive U.S. commercialization agreement. Verséa Ophthalmics will distribute Celularity's BIOVANCE and BIOVANCE 3L Ocular products, which are intended for the treatment of ocular surface disease and ocular surgical applications. The global persistent corneal epithelial defect management market, which these products target, is valued at $8.5 billion and expected to grow at an 18% CAGR through 2033.

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 1:13 pm